Select Page

Home / Share Price Target / Indramedco

INDRAMEDCO (Small Cap - Potential Multibagger) Share Target 2026, 2027 To 2035

By Nippun

Indraprastha Medical Corporation Limited

Company Logo Price: ₹385.95 (0.38%)
52 Week Low: ₹342.00
52 Week High: ₹640.85
Market Capital: 3,731.09 Crore (Small-cap)
Healthcare -> Medical Care Facilities
Share Price HistoryINDRAMEDCO FinancialsTomorrow TargetYearly TargetsDividend HistoryNo BonusNo Split
Show Table of Contents
Table of Contents

INDRAMEDCO, a Small Cap company in the Medical Care Facilities Industry has delivered 338.9% returns in 5-year showing 10.4% quarterly revenue growth with 11.2% profit margin, making it a potential Multibagger.

To predict the INDRAMEDCO's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

INDRAMEDCO Share Price Target For 2026

The line chart displays the monthly closing prices of INDRAMEDCO with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for INDRAMEDCO shares in 2026, see the table below.

INDRAMEDCO Share Price Target Table For 2026

Level Value Analysis
2026 Target 3 408.35 (+5.8%) Volatility: BB Upper
2026 Target 2 407.73 (+5.64%) Trend: Supertrend Resistance
2026 Target 1 398.16 (+3.16%) Trend: SMA50
Current Price 385.95 INDRAMEDCO's share price as of 15 Jun 2026
Stop Loss 1 385.47 (-0.13%) Trend: EMA9
Stop Loss 2 351.02 (-9.06%) Volatility: BB Lower
Stop Loss 3 346.18 (-10.31%) 98.60% Weekly Fib Retrace

Short-Term Technical Outlook

Current Technical Position: INDRAMEDCO is displaying bearish momentum trading below key moving averages.

Key Technical Level: The 50-day moving average at ₹398.16 serves as the nearest technical reference point.

Historical Returns: 3-month: -1.44% | 6-month: -21.11% | 1-year: -5.84%

INDRAMEDCO Share Price Target For 2027

The line chart displays the monthly closing prices of INDRAMEDCO with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for INDRAMEDCO shares in 2027, see the table below.

INDRAMEDCO Share Price Target Table For 2027

Level Value Analysis
2027 Target 3 408.35 (+5.8%) Volatility: BB Upper
2027 Target 2 407.73 (+5.64%) Trend: Supertrend Resistance
2027 Target 1 398.16 (+3.16%) Trend: SMA50
Current Price 385.95 INDRAMEDCO's share price as of 15 Jun 2026
Stop Loss 1 385.47 (-0.13%) Trend: EMA9
Stop Loss 2 351.02 (-9.06%) Volatility: BB Lower
Stop Loss 3 346.18 (-10.31%) 98.60% Weekly Fib Retrace

Long-Term Technical Outlook

52-Week Range Analysis: INDRAMEDCO is currently trading near its 52-week low of ₹342, indicating potential value opportunity.

Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.

Long-Term Performance: 1-year: -5.84% | 3-year: +323.69% | 5-year: +338.93%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our Telegram channel

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

INDRAMEDCO Share Price Target Chart and Table From 2026, 2027, 2028 to 2035

Year Target 1 Target 1 YoY Chg % Target 2
Current Price ₹385.95
2026 ₹497.51 +28.90529861381% ₹504.97
2027 ₹721.21 +44.96392032321% ₹732.03
2028 ₹913.56 +26.67045659378% ₹927.26
2029 ₹1,270.91 +39.11620473751% ₹1,289.97
2030 ₹1,714.50 +34.903336979015% ₹1,740.22
2031 ₹2,300.91 +34.202974628171% ₹2,335.42
2032 ₹3,032.90 +31.813065265482% ₹3,078.39
2033 ₹3,776.92 +24.531636387616% ₹3,833.57
2034 ₹4,751.11 +25.793238935429% ₹4,822.38
2035 ₹5,814.42 +22.380243774613% ₹5,901.64

Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.

INDRAMEDCO Brief Company Overview

```html Indraprastha Medical Corporation Limited: A Healthcare Giant in India Indraprastha Medical Corporation Limited, established in 1983, is a leading provider of comprehensive hospital services in India. Based in New Delhi, the company has a strong presence across the... country. Diverse Product Range: Indraprastha Medical offers a wide range of medical services, including sugar management, genomic medicine, elder care, cardiology, oncology, emergency care, gastroenterology, neurology, orthopedics, pediatrics, ophthalmology, and more. Industry Reputation: The company has consistently maintained a strong reputation for its quality healthcare services. Its experienced medical professionals and state-of-the-art facilities have earned it recognition as a trusted healthcare provider. Commitment to Excellence: Indraprastha Medical is committed to providing affordable and accessible healthcare to all. Its commitment to innovation and patient care ensures that its services are constantly evolving to meet the changing needs of the healthcare industry. ```

INDRAMEDCO Financial Performance

Metric Value Description
Market Capital 3,786.53 Crore Market valuation of INDRAMEDCO's shares.
Revenue (TTM) 1,318.87 Crore Total revenue generated by INDRAMEDCO over the past twelve months.
Net Income (TTM) +147.77 Crore Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin 14.99% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin 11.2% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)		 +10.4% Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)		 +29.1% Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio		 6.24 Company's total debt divided by total shareholder equity.
Total Debt 32.74 Crore Sum of INDRAMEDCO's current & long-term financial obligations.
Total Cash 309.34 Crore Total amount of liquid funds available to INDRAMEDCO.
Beta 0.81 Beta is less than 1 indicating that the INDRAMEDCO's price is less volatile than the market.

Is INDRAMEDCO A Good Buy For Long Term?

Indramedco, a small-cap stock with a market capitalization of ₹3,786.53 crore, shows strong growth potential. Its 12-month net profit of ₹147.77 crore on ₹1,318.87 crore revenue, coupled with an 11.2% profit margin, is impressive. While its debt is relatively low at ₹32.74 crore against a cash balance of ₹309.34 crore, the exceptionally high past returns (153.85% in 12 months, 977.82% over 5 years) raise concerns about sustainability. Further investigation into growth drivers is needed. While the current data is positive, it's too early to definitively label it a "good buy" for long-term investors; more due diligence is recommended.

Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.

All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.